J. Gaddy et al., CORD-BLOOD NATURAL-KILLER-CELLS ARE FUNCTIONALLY AND PHENOTYPICALLY IMMATURE BUT READILY RESPOND TO INTERLEUKIN-2 AND INTERLEUKIN-12, Journal of interferon & cytokine research, 15(6), 1995, pp. 527-536
Human umbilical cord blood (CB) is being increasingly used both as an
alternative to bone marrow to transplant children and for experimental
insight into the ontogenic and maturational characteristics of blood
cells, We studied the functional and phenotypic characteristics of CB
natural killer (NK) cells because of the possibly important role such
cells may play in a transplant setting and to gain insight into the li
ttle known ontogenic differences and maturational pathways of NK cells
, It was found that CB NK lytic activity is usually deficient and that
this deficiency cannot be fully explained by the presence of insuffic
ient percentages of CD56(+) cells, Although CD16(+)CD56(+) and CD16(-)
CD56(+) NK cell subsets typical of adult peripheral blood (PB) are pre
sent, a significant population of CD16(+)CD56(-) cells also exists in
CB, CB CD16(+)CD56(-) cells have little or no lytic capabilities; CB C
D16(+)CD56(+) cells vary in their lytic capabilities, Although a decre
ased ability to bind target cells may contribute to the deficient lyti
c activity of these CB NK cell subsets, studies suggest that other fac
tors must also play a role, Short-term incubation with interleukin-2 (
IL-2) or interleukin-12 (IL-12) substantially increases the lytic capa
bilities of CB NK cells, and long-term incubations induce lymphokine-a
ctivated killer (LAK) cell generation, Cell depletion experiments show
that activated CD56(+) NK cells are responsible for the lytic activit
y of CB LAK cells, Flow cytometric analysis reveals that during LAK ce
ll generation, CB undergoes phenotypic changes similar to those of PB
except that CD16(+)CD56(-) cells are still present, These findings dem
onstrate that CB NK cells are functionally deficient and phenotypicall
y different in comparison with PB NK cells, yet are responsive to IL-2
and IL-12 in the ability both to increase lytic activity and to under
go phenotypic change.